Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.
BIOMEDICA CRO – 5 years of being your global biospecimen partner
Dear Partners, Today we celebrate our firs...
Alternative therapy for Diabetic patients and biospecimen CRO services
Patients with Diabetes may expect to receive ...
TILs therapy and how BIOMEDICA CRO may help to move science forward
TIL therapy is a type of treatment in which T...
Prospective collection of blood for novel Liquid Biopsy test development
Prospective collection of biospecimens for Au...
Cancer gene mutations research and contribution of human biospecimens providers
Researchers identified new mutations that dri...
Pregnancy – related Hypertension studies and the role of biospecimens providers
The link between pregnancy accompanied by Pre...
Non-stop cancer patients research and the role of biospecimens providers
Study shows that some cancer patient...
BIOMEDICA CRO can support Traumatic Brain Injury (TBI) researches
Prospective collection of biospecime...
